IRIS - Res&Arch Institutional Research Information System - Research & Archive

MARTINO, Sabata
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.091
EU - Europa 4.517
AS - Asia 1.475
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 5
OC - Oceania 4
AF - Africa 3
Totale 11.104
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.926
IE - Irlanda 923
UA - Ucraina 917
IT - Italia 697
SE - Svezia 505
SG - Singapore 501
HK - Hong Kong 433
DE - Germania 355
FI - Finlandia 256
VN - Vietnam 250
FR - Francia 249
RU - Federazione Russa 226
GB - Regno Unito 222
CN - Cina 191
CA - Canada 158
CH - Svizzera 42
TR - Turchia 35
CZ - Repubblica Ceca 28
KR - Corea 25
BE - Belgio 20
NL - Olanda 20
PL - Polonia 17
AT - Austria 15
UZ - Uzbekistan 14
JP - Giappone 12
LB - Libano 10
EU - Europa 7
MX - Messico 7
GR - Grecia 6
DK - Danimarca 4
AU - Australia 3
BG - Bulgaria 3
CO - Colombia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
ES - Italia 2
ID - Indonesia 2
NO - Norvegia 2
PT - Portogallo 2
HU - Ungheria 1
IR - Iran 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 11.104
Salva come PNG Salva come JPEG
Città #
Chandler 1.018
Dublin 923
Jacksonville 507
San Mateo 495
Hong Kong 426
Singapore 371
Boardman 321
Perugia 301
Dong Ket 250
Medford 228
Princeton 227
Wilmington 172
Montréal 150
Ann Arbor 139
Altamura 138
Munich 120
Lawrence 112
Andover 108
Beijing 99
Ashburn 98
Mcallen 86
Des Moines 82
Saint Petersburg 72
Helsinki 59
Norwalk 51
Shanghai 42
Izmir 33
Woodbridge 33
Los Angeles 28
Redmond 27
Seoul 25
Philadelphia 24
Brno 23
Rome 22
San Paolo di Civitate 22
New York 21
Auburn Hills 19
Redwood City 19
Brussels 17
Falls Church 16
Moscow 14
San Diego 14
Città Di Castello 13
Dallas 12
Santa Clara 12
Den Haag 11
Houston 10
London 10
Cambridge 9
Milan 9
Lausanne 8
Florence 7
Paris 7
Terni 7
Fairfield 6
Gubbio 6
Simi Valley 6
Bromley 5
Central 5
Dearborn 5
Detroit 5
Tokyo 5
Vienna 5
Amsterdam 4
Assisi 4
Chicago 4
Desio 4
Egham 4
Frankfurt Am Main 4
Guangzhou 4
Lincoln 4
Mexico City 4
Nanjing 4
Sesto Fiorentino 4
Windsor 4
York 4
Arlington 3
Bogotá 3
Boston 3
Concord 3
Copenhagen 3
Crewe 3
Espoo 3
Esslingen am Neckar 3
Fremont 3
Gustavo Adolfo Madero 3
Higashiikebukuro 3
Kazan' 3
Nuremberg 3
Piediluco 3
Renton 3
Stockholm 3
Tama 3
Toronto 3
Zurich 3
Abidjan 2
Alexandria 2
Anchorage 2
Bristol 2
Böblingen 2
Totale 7.234
Salva come PNG Salva come JPEG
Nome #
Nanostructured Biopolymer-based Materials for Regenerative Medicine Applications 474
Keratins extracted from Merino wool and Brown Alpaca fibres: thermal, mechanical and biological properties of PLLA based biocomposites 110
Tuning Stem Cells Fate by PLLA-based materials: A Matter of Mechanotransduction. 97
Carbon nanotubes and silver nanoparticles for multifunctional conductive polymer composites 96
In vivo HSV-1 T0Ahex gene transfer strategy for Tay-Sachs disease provides a wide distribution of B-Hexosaminidase A and restores the GM2 ganglioside metabolims in the brain animal model 93
Intracerebral gene therapy in children with metachromatic leukodystrophy: Results of a phase I/II trial 88
Lysosomal enzymes in alzheimer disease and type 2 diabetes mellitus patients 87
Caspase 3 mediated PARP cleavage in lymphocytes from newborn babies of diabetic mothers 87
Cellule staminali e GM2 gangliosidosi 86
Influence of cell differentiation and protein kinase C activation on sub-cellular distribution of beta-N-acetylhexosaminidases of HL 60 cells. 85
Adult neural stem cells as a tool for gehe therapy of Tay-Sachs disease 81
Adipose stem cell translational applications: From bench-to-bedside 80
Restoration of hexosaminidase A activity and GM2 ganglioside metabolism in cells from patients with Tay-Sachs Disease 79
Expression of human a-subunit gene in the central nervous system of the Tay-Sachs animal model 79
Implication of Cathepsins S and D in TPO+IL-16-induced commitment of hematopoietic stem cell differentiation into tolerogenic dendritic cells 79
Human bone marrow mesenchymal stem cell guidance by a-C:H surface designes 79
The processing of cysteinyl proteases during human hematopoietic stem cell commitment to CD1a-Dendritic cells 78
Lysosomal beta-Galactosidase and beta-Hexosaminidase Activities Correlate with Clinical Stages of Dementia Associated with Alzheimer's Disease and Type 2 Diabetes Mellitus 78
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 77
A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: Implications for regenerative medicine approaches 76
Lentiviral hematopoietic stem and progenitor cell gene therapy (HSPC-GT) for metachromatic leukodystrophy (MLD): Clinical outcomes from 33 patients 76
Approcci di terapia genica per le malattie da accumulo metabolico lisosomiale con coinvolgimento neurologico 75
Therapy for Lysosomal Storage Disorders: a Matter for Stem Cells 74
a-C:H NANOPATTERNED FILM DESIGNS DRIVE HUMAN BONE MARROW MESENCHYMAL STEM CELL CYTOSKELETON ARCHITECTURE 74
Absence of metabolic cross-correction in tay-sachs cells: implication in gene therapy 73
Hydrogenated Amorphous Carbon Nanopatterned Film Designs Drive Human Bone Marrow Mesenchymal Stem Cell Cytoskeleton Architecture 73
b-Hexosaminidase and altered cell-mediated immuno-responce 72
Advanced Tools of Regenerative Medicine for Neurodegenerative Diseases 70
Protein Encapsulation in Biodegradable Polymeric Nanoparticles: Morphology, Fluorescence Behaviour and Stem Cell Uptake 70
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 69
Sistemi di "Drug delivery di B-esosaminidasi nella mallattia di Tay-Sachs 68
Alpha and Beta subunits of b-N-acethyl-hexosaminidase are differently regulated during the mammalian brain development: implication for Tay-Sachs disease therapy 67
Acid glycohydrolases activities in linphomonocytes plasma-membrane of patients with multiple sclerosis 67
a-C:H nanopatterned grooves influence human bone marrow stromal stem cells orientation 66
Proteomics and Epigenetic Mechanisms in Stem Cells 66
Analysis of galactocerebrosidase activity in the mouse brain by a-new hysological staining method 65
The processing of cysteinyl proteases during human hematopoietic stem cell commitment to CD1a-Dendritic cells 64
Absence of metabolic cross-correction in Tay-Sachs cells: implication in gene therapy 64
In vivo gene therapy approach using herpes simplex vector for Tay-Sachs disease 63
B-Hexosaminidase and antigen presenting cells function: implication for neurodegenerative process in GM2 gangliosidosis 63
Integrated Computational Analysis Highlights unique miRNA Signatures in the Subventricular Zone and Striatum of GM2 Gangliosidosis Animal Models 63
Tuning multi pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats. 62
Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial 62
Localizzazione e caratterizzazione biochimica di forma di membrana nella b-n-acetilesosaminidase 61
Gene expression profiling identifies ARSD as a new marker of disease progression and the sphingolipid metabolism asa potential novel metabolism in Chronic Lymphocytic Leukemia 61
Adult neural stem cells as a tool for gene therapy for Tay-Sachs disease. 61
Widespread enzymatic correction of CNS tissues by a single intracerebral injection of therapeutic lentiviral vector in leukodystrophy mouse models. 60
Stem cell-biomaterial interactions for regenerative medicine 60
Efficient lentiviral vector-mediated delivery of hARSA in the brain of juvenile non-human primates 60
Efficacy of combined gene/cell therapy in a murine model of Globoid cell Leukodystrophy 60
B-hexosaminidase isoenzymes and antigen presenting cell function: implication for neurodegenerative process in GM2-gangliosidosis 59
ARSD as a new biomarker associated with IGVH, ZAP-70, and disease progression in CLL. 59
Carbon nanotubes and silver nanoparticles for multifunctional conductive biopolymer composites 59
The influence of modified silica nanomaterials on adult stem cell culture 59
Osteogenic Induction in human Bone Marrow mesenchymal Stem Cells by nonocomposite Scaffold 58
Beta-Hexosaminidase and immuno-response: implications for the neurodegenerative process in GM2 gangliosidosis 58
Beta-Hexosaminidase expression is recapitulated in Neural Stem Cells induced to differentiate and in embryonic to adult brain development in both WT and knock-out mice 58
Biocompatible Poly(l-lactide)/MWCNT Nanocomposites: Morphological Characterization, Electrical Proprieties, and Stem Cell Interation. 58
Effect of SWCNT introduction in random copolymers on material properties and fibroblast long term culture stability 58
Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients 58
Above the Epitranscriptome: RNA Modifications and Stem Cell Identity 58
Novel nanocomposite PLA films with lignin/zinc oxide hybrids: Design, characterization, interaction with mesenchymal stem cells 58
Modulating protein adsorption onto biomaterials by surface plasma treatment-VI Convegno Nazionale sulla Scienza e Tecnologia dei Materiali 57
Nanocomposites Based on PLLA and Multi Walled Carbon Nanotubes Support the Myogenic Differentiation of Murine Myoblast Cell Line 57
Brain-directed gene transfer therapy for Tay-Sachs disease gives rice a wider distribution of the B-Hexosaminidase A 56
Beta-hexosaminidase and antigen presenting cell function: implication for neurodegenerative process in GM2 gangliosidosis. 56
Regulation of neural stem cell compartment in a murine model of GM2-gangliosidosis: potential role of EGF and GM3 ganglioside 56
Overcoming GALC toxicity in Hematopoietic Stem Cell gene therapy for Globoid cell leukodystrophy 56
Acid glycohydrolase activities in lymphomonocyte plasma- membranes of patients with multiple sclerosis 56
Optimized bicistronic lentiviral vectors to correct beta-hexosaminidase deficiency in neural and hematopoietic stem/progenitor cells and progeny 56
Novel bicistronic lentiviral vectors correct β-Hexosaminidase deficiency in neural and hematopoietic stem cells and progeny: implications for in vivo and ex vivo gene therapy of GM2 gangliosidosis 56
STEM CELL NICHE AND LYSOSOMAL CATHEPSINS 55
Inclusion of multi walled carbon nanotubes on PLLA supports the myogenic differentiation of murine progenitor cells 55
Characterization and localization of plasma membrane B-N-acetylhexosaminidases 55
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy 55
The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers 55
"Terapia delle malattie neurodegenerative con cellule staminali: overview sullo stato attuale" 54
Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement theraphy 54
Knock-down of HEXA and HEXB genes correlate with the absence of the immunostimulatory function of HSC-derived dendritic cells 54
Human neural crest-derived postnatal cells exhibit remarkable embryonic attributes either in vitro or in vivo. 54
Nano-engineered PLLA based biomaterial drives stem cell responses 54
Insight into mechanobiology: How stem cells feel mechanical forces and orchestrate biological functions 54
Le cellule staminali per la terapia delle GM2 gangliosidosi 53
Stem cell niche and lysosomal cathepsins 53
Neural Stem Cell Gene Therapy Ameliorates Pathology And Function In A Mouse Model Of Globoid Cell Leukodystrophy 53
Design of a nanocomposite substrate inducing adult stem cell assembly and progression toward an Epiblast-like or Primitive Endoderm-like phenotype via mechanotransduction 53
MicroRNAs and Molecular Mechanisms of Neurodegeneration 53
The role of physical cues in the development of stem cell-derived organoids 53
Microarray Gene Expression Signature Indicates ARSD As a New Marker Associated with Igvh Mutational Status, ZAP-70 and Disease Progression in CLL 52
MicroRNA mediated lysosomal enzymes down-regulation in cell of peripheral system from aAlzheimer's disease patients 52
Nitric oxide depletion alters hematopoietic stem cell commitment toward immunogenic dendritic cells 52
Human iPSC-based models highlight defective glial and neuronal differentiation from neural progenitor cells in metachromatic leukodystrophy 52
MICROPATTERNED HYDROGENATED AMORPHOUS CARBON GUIDES MESENCHYMAL STEM CELLS TOWARDS NEURONAL DIFFERENTIATION 52
Functionalized silica star-shaped nanoparticles and human mesenchymal stem cells: An in vitro model 52
Neural precursor cell cultures from GM2-gangliosidosis murine models recapitulate the biochemical hallmarks of the brain pathology 51
Le cellule staminali stromali di midollo osseo umane sono orientate da nanotopografie di carbonio amorfo idrogenato 51
Ex-vivo tissues engineering modeling for reconstructive surgery using human adult adipose stem cells and polymeric nanostructured matrix 51
A New Analytical Bench Assay for the Determination of Arylsulfatase A Activity Toward Galactosyl-3-Sulfate Ceramide: Implication for Metachromatic Leukodystrophy Diagnosis 51
Lentiviral haematopoietic stem cell gene therapy (HSC-GT) for metachromatic leukodystrophy (MLD): Preliminary results from a clinical trial with a cryopreserved formulation of OTL-200 51
Effect of Amorphous Carbon Nano-patterns on Human Bone Marrow Stromal Stem Cells - 8th World Biomaterials Congress 2008 50
Totale 6.818
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.789
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.789
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020870 0 0 0 0 195 109 185 40 175 87 20 59
2020/20211.939 32 148 63 144 563 94 153 5 222 61 171 283
2021/20221.774 29 367 73 98 55 21 21 535 15 68 201 291
2022/20233.166 254 452 62 229 280 387 18 148 1.187 9 113 27
2023/20241.547 206 143 85 30 18 18 282 72 207 56 137 293
2024/2025653 49 330 150 113 11 0 0 0 0 0 0 0
Totale 11.656